All Policies Include Coronavirus Cover
Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30
Coronavirus FAQs
Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.
04 June 2014 08:43
Scientists say one in four smokers with the defective gene BRCA2 will develop lung cancer
New research has discovered that a quarter of smokers with the defective gene BRCA2 will suffer from lung cancer during their lives.
The mutated gene, which is found in 2% of humans, has been associated with ovarian cancer and breast cancer for some time but now scientists say those who have it are nearly twice as likely as other people to have cancer of the lungs.
Around 13% of the 10 million Brits who smoke develop the disease during their lives but the risk is 25% among those with the gene flaw, as many as 200,000 people.
The leader of the research, Professor Richard Houlston, said that for smokers with the defective gene the risks of lung cancer are huge. The academic from the Institute of Cancer Research in London said the disease kills more people in Britain than any other cancer and as many as a million people around the world every year. The best way to prevent it is not smoking but it is even more crucial for people with the BRCA2 flaw, he said.
The study of 17,000 people across Europe, some with lung cancer and some without, looked for key differences and discovered a clear link between the disease and those participants with the c.9976T alteration to the BRCA2 gene. The connection was even more evident in those suffering from the most common type of the disease, known as squamous cell lung cancer. The scientists also found a connection between squamous cell lung cancer and another gene called CHEK2. Those suffering from the disease can arrange cancer travel insurance to protect them while on holiday.
Professor Houlston and his team think the findings from the study, which have been revealed in the Nature Genetics journal, could change the way people with the BRCA2 gene and lung cancer are treated in the future.
Doctors treating cancer patients with the BRCA2 gene who have developed breast or ovarian cancer have had some success by giving them drugs known as PARP inhibitors, but it is not yet known how they affect lung cancer, which is usually a fatal condition.
28 February 2020
From tulip-filled trips to rose-tinged rests, these destinations are the perfect way to see in the new season.
[more...]
04 January 2021
Join us on a journey to Ancient Greece to discover more about history's most revered statue.
Head north for a light show like no other. Discover how you can see the Northern Lights for yourself.
Discover more about the magnificent waterfall perched on the border of Zambia and Zimbabwe.
10 December 2020
Don't sleep on the world's most impressive dormant volcano.
A destination that stands head and shoulders above the rest.
19 November 2020
Take a tour of one of South America's most captivating natural landscapes.
Discover the hidden depths of the world's most recognisable desert gorge.
It's the question on everyone's mind right now - unfortunately, there's still no easy answer...
Discover why planes are more hygienic than you might think.
Dive into Queensland's colourful coral.
02 November 2020
With the global travel industry slowly getting back on its feet, it's a great time for holiday bargain hunters. Here are our top tips for 2021.